Phosphoproteomic analysis of basal and therapy-induced adaptive signaling networks inBRAFandNRASmutant melanoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphoproteomic analysis of basal and therapy-induced adaptive signaling networks inBRAFandNRASmutant melanoma
Authors
Keywords
-
Journal
PROTEOMICS
Volume 15, Issue 2-3, Pages 327-339
Publisher
Wiley
Online
2014-10-22
DOI
10.1002/pmic.201400200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating Melanoma Drug Response and Therapeutic Escape with Quantitative Proteomics
- (2014) Vito W. Rebecca et al. MOLECULAR & CELLULAR PROTEOMICS
- Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib
- (2014) J. Acquaviva et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin inBRAFwild-type melanoma
- (2014) Vito W. Rebecca et al. Pigment Cell & Melanoma Research
- Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas
- (2013) Fang Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
- (2013) Paolo A Ascierto et al. LANCET ONCOLOGY
- MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines
- (2013) A Vultur et al. ONCOGENE
- Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibition
- (2013) D. S. Kirkpatrick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
- (2013) N. Wagle et al. Cancer Discovery
- The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
- (2013) E. M. Van Allen et al. Cancer Discovery
- Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
- (2012) Piro Lito et al. CANCER CELL
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- (2012) James S. Duncan et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms
- (2012) K. H. T. Paraiso et al. CLINICAL CANCER RESEARCH
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
- (2012) L. C. W. Vredeveld et al. GENES & DEVELOPMENT
- GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N-Cadherin Expression and Decreasing FAK Phosphorylation
- (2012) Jobin K. John et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- NRAS mutant melanoma: biological behavior and future strategies for therapeutic management
- (2012) I V Fedorenko et al. ONCOGENE
- Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
- (2012) Maria R. Girotti et al. Cancer Discovery
- Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
- (2011) Inna V. Fedorenko et al. BIOCHEMICAL PHARMACOLOGY
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A
- (2011) Imanol Arozarena et al. CANCER CELL
- PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression
- (2011) K. H. T. Paraiso et al. CANCER RESEARCH
- Association of activated c-Met with NRAS-mutated human melanomas
- (2011) Chandrani Chattopadhyay et al. INTERNATIONAL JOURNAL OF CANCER
- Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers
- (2011) Hiromichi Ebi et al. JOURNAL OF CLINICAL INVESTIGATION
- Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase
- (2011) Marialuisa Sensi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phosphoproteomic Screen Identifies Potential Therapeutic Targets in Melanoma
- (2011) K. Tworkoski et al. MOLECULAR CANCER RESEARCH
- Cytoscape 2.8: new features for data integration and network visualization
- (2010) M. E. Smoot et al. BIOINFORMATICS
- Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs
- (2010) María Ines Díaz Bessone et al. BREAST CANCER RESEARCH AND TREATMENT
- Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
- (2010) K H T Paraiso et al. BRITISH JOURNAL OF CANCER
- Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma Cells
- (2010) Y. N. V. Gopal et al. CANCER RESEARCH
- A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
- (2010) Jiannong Li et al. Nature Chemical Biology
- Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy
- (2009) K. S.M. Smalley et al. CANCER RESEARCH
- Rnd3 Regulation of the Actin Cytoskeleton Promotes Melanoma Migration and Invasive Outgrowth in Three Dimensions
- (2009) R. M. Klein et al. CANCER RESEARCH
- Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
- (2009) William M. Old et al. MOLECULAR CELL
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics
- (2009) Jürgen Cox et al. Nature Protocols
- The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
- (2009) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
- Mutant B-RAF mediates resistance to anoikis via Bad and Bim
- (2008) K Boisvert-Adamo et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now